x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Hematologic Oncology Update

Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.

science medicine

All Episodes

58:41

Multiple Myeloma — Proceedings from a Webinar Held in...

Hematologic Oncology Update ·

2025/07/18

Dr Ajay K Nooka from Winship Cancer Institute of Emory University in Atlanta, Georgia, and Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss recent updates on available and novel treatment strategies for multiple myeloma.CME information and select publications here.

en

01:30:22

For Oncology Nurses: Chronic Lymphocytic Leukemia —...

Hematologic Oncology Update ·

2025/07/14

Dr Bita Fakhri, Dr Jeff Sharman, and nurse practitioners Dr Jacqueline Broadway-Duren and Ms Corinne Hoffman discuss the current treatment landscape for chronic lymphocytic leukemia and strategies to mitigate and manage treatment-emergent adverse events.NCPD information and select publications here.

en

01:59:42

Non-Hodgkin Lymphoma — Proceedings from a Session...

Hematologic Oncology Update ·

2025/07/10

Dr Jeremy Abramson from Massachusetts General Hospital in Boston, Dr Joshua Brody from the Tisch Cancer Institute in New York, New York, Dr Christopher Flowers from The University of Texas MD Anderson Cancer Center in Houston, Dr Ann LaCasce from Dana-Farber Cancer Institute in Boston, Massachusetts, and Dr Tycel Phillips from City of Hope Comprehensive Cancer Center in Duarte, California, discuss patient cases and provide their perspectives on clinical datasets informing the care of patients with

en

01:26:53

For Oncology Nurses: Non-Hodgkin Lymphoma —...

Hematologic Oncology Update ·

2025/07/05

Dr Christopher Flowers and Dr Manali Kamdar summarize the clinical treatment landscape for patients with non-Hodgkin lymphoma, supported by clinical perspectives and management strategies from nurse practitioners Ms Robin Klebig and Ms Caitlin Murphy.NCPD information and select publications here.

en

01:26:22

For Oncology Nurses: Chronic Myeloid Leukemia —...

Hematologic Oncology Update ·

2025/06/28

Dr Michael Mauro, Dr Neil Shah, and nurse practitioners Ms Ilene Galinsky and Dr Sara Tinsley-Vance discuss important nursing considerations in the modern treatment of chronic myeloid leukemia.NCPD information and select publications here.

en

54:07

IDH-Mutant Low-Grade Glioma — An Interview with Dr...

Hematologic Oncology Update ·

2025/06/24

Dr Patrick Wen from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses the current and future management of IDH-mutant gliomas.CME information and select publications here.

en

59:09

Multiple Myeloma — Year in Review Series on Relevant...

Hematologic Oncology Update ·

2025/06/18

Prof Meletios-Athanasios (Thanos) C Dimopoulos from the National and Kapodistrian University of Athens and Alexandra Hospital in Athens, Greece, and Dr Robert Z Orlowski from The University of Texas MD Anderson Cancer Center in Houston, Texas, provide their perspectives on relevant new clinical data in multiple myeloma and their application to disease treatment.CME information and select publications here.

en

59:18

Year in Review: Clinical Investigator Perspectives on...

Hematologic Oncology Update ·

2025/06/11

Professor Claire Harrison from the Guy’s and St Thomas’ NHS Foundation Trust in London, United Kingdom, and Dr John Mascarenas from The Tisch Cancer Institute in New York, New York, provide their perspectives on relevant new clinical data in myelofibrosis and discuss their application to treatment.CME information and select publications here.

en

59:08

Non-Hodgkin Lymphoma — Year in Review Series on...

Hematologic Oncology Update ·

2025/06/05

Dr Stephen Ansell from Mayo Clinic in Rochester, Minnesota, and Dr Brian Hill from Cleveland Clinic Taussig Cancer Institute in Ohio summarize major treatment advances over the past year and review relevant ongoing clinical trials for patients with non-Hodgkin lymphoma.CME information and select publications here.

en

47:55

Systemic Mastocytosis and Myelofibrosis — Fourth...

Hematologic Oncology Update ·

2025/06/02

Clinical investigators discuss available data guiding the management of systemic mastocytosis and myelofibrosis. CME information and select publications here.

en

50:41

Multiple Myeloma — Fourth Annual National General...

Hematologic Oncology Update ·

2025/05/31

Clinical investigators discuss available data guiding the management of multiple myeloma. CME information and select publications here.

en

50:50

Multiple Myeloma — An Interview with Dr Rafael...

Hematologic Oncology Update ·

2025/05/29

Dr Rafael Fonseca from Mayo Clinic in Phoenix, Arizona, discusses datasets from the 2024 ASH meeting on the management of newly diagnosed and relapsed/refractory multiple myeloma.CME information and select publications here.

en

48:22

Chronic Lymphocytic Leukemia — An Interview with Dr...

Hematologic Oncology Update ·

2025/05/25

Dr Lindsey Roeker from Mayo Clinic in Rochester, Minnesota, discusses recent updates on available and novel treatment strategies for chronic lymphocytic leukemia.CME information and select publications here.

en

42:34

Relapsed/Refractory Follicular Lymphoma Part 3 — A...

Hematologic Oncology Update ·

2025/05/23

Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lymphoid Cancer in Vancouver discuss recent updates on available and novel treatment strategies for relapsed/refractory follicular lymphoma.CME information and select publications here.

en

49:54

Non-Hodgkin Lymphoma — An Interview with Dr Jennifer...

Hematologic Oncology Update ·

2025/05/20

Dr Jennifer Crombie from the Dana-Farber Cancer Institute in Boston, Massachusetts, reviews available and investigational CD20 x CD3 targeted bispecific antibodies for the treatment of follicular and diffuse large B-cell lymphomas.CME information and select publications here.

en

37:08

Relapsed/Refractory Follicular Lymphoma Part 2 — A...

Hematologic Oncology Update ·

2025/05/16

Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lymphoid Cancer in Vancouver discuss recent updates on available and novel treatment strategies for relapsed/refractory follicular lymphoma.CME information and select publications here.

en

50:03

Non-Hodgkin Lymphoma — Fourth Annual National General...

Hematologic Oncology Update ·

2025/05/12

Clinical investigators discuss available data guiding the management of non-Hodgkin lymphoma. CME information and select publications here.

en

52:36

Non-Hodgkin Lymphoma — An Interview with Dr John P...

Hematologic Oncology Update ·

2025/05/10

Dr John P Leonard from Weill Cornell Medicine in New York, New York, reviews data presented at the 2024 ASH Annual Meeting and their implications for the treatment of non-Hodgkin lymphomas.CME information and select publications here.

en

59:14

Chronic Lymphocytic Leukemia — Year in Review Series...

Hematologic Oncology Update ·

2025/05/03

Dr Jennifer R Brown from Dana-Farber Cancer Institute in Boston and Prof Paolo Ghia from IRCCS Ospedale San Raffaele in Milano, Italy, summarize clinically relevant research findings and datasets over the past year regarding the treatment of chronic lymphocytic leukemia.CME information and select publications here.

en

01:56:57

Immune Thrombocytopenia — A Roundtable Discussion on...

Hematologic Oncology Update ·

2025/04/28

Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston, Dr James B Bussel from Weill Cornell School of Medicine in New York, New York, and Prof Nichola Cooper from Hammersmith Hospital Campus in London, United Kingdom, share expert perspectives on the diagnosis of and optimal management strategies for immune thrombocytopenia.CME information and select publications here.

en

595 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter